NIH-funded research R21 grant

Investigating brain metabolism using advanced MRI technology

Official title: Feasibility and reproducibility of hyperpolarized 13C pyruvate human brain imaging on a new MRI scanner platform

Funded at Washington University · NIH-10988936 · Data updated 2026-11-12

This study is testing a new type of MRI that helps us see how sugar is used in the brain, which could give us important information about brain aging and diseases, and it’s designed for people interested in understanding more about brain health.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 15, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$233,250
NIH project number1R21AG085245-01A1
Project IDNIH-10988936 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who may be experiencing neurological disorders or cognitive decline.

Less likely to help

Patients with conditions unrelated to brain metabolism or those under 21 years old may not benefit from this research.

What this research studies

This research focuses on a new imaging technique called hyperpolarized 13C pyruvate MRI, which allows for detailed observation of glucose metabolism in the brain. By using a specialized MRI scanner, the study aims to assess the feasibility and reproducibility of this method for understanding brain aging and neurodegeneration. The research will first test the imaging technique in a lab setting using a 3D-printed model that simulates human brain conditions, followed by evaluations in actual human subjects. This innovative approach could provide valuable insights into metabolic processes that are crucial for diagnosing and treating neurological disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic capabilities for brain diseases and better understanding of metabolic changes associated with neurodegeneration.

How similar studies have gone: While some prior research has utilized hyperpolarized 13C MRI, this specific approach on the Siemens platform is novel and has not been extensively tested in human subjects.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Von Morze, Cornelius — Washington University
  • Study coordinator: Von Morze, Cornelius

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.